Government Reform Committee
This article was originally published in The Tan Sheet
Executive Summary
House hearing on dietary supplement issues scheduled to be held Feb. 28. Potential points of discussion and testimony include Codex, ephedra, Pearson implementation and GMPs. Committee Chairman Dan Burton (R-Ind.) postponed a Dec. 27 hearing on FDA's position regarding ephedrine alkaloid-containing supplements after receiving confirmation from FDA it had no plans to act immediately on the matter (1"The Tan Sheet" Jan. 8, p. 11)
You may also be interested in...
Government Reform Cmte. Ephedra Hearing Still Possible Pending FDA Stance
The House Government Reform Committee still is considering holding a hearing on FDA's position regarding ephedrine alkaloid-containing dietary supplements.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands